NDC 50268-145 – Buprenorphine HCl and Naloxone HCl

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC50268-145

Product details

Brand name
Buprenorphine HCl and Naloxone HCl
Generic name
Buprenorphine and Naloxone
Labeler
AvPAK
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA203136
Marketed since
December 8, 2016
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine HCl and Naloxone HCl →

Package NDC codes (1)

Package NDCDescriptionSince
50268-145-1550 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-145-15) / 1 TABLET in 1 BLISTER PACK (50268-145-11)Dec 8, 2016

Other Buprenorphine HCl and Naloxone HCl products